Answers are grounded in this paper and cite their sources.
Spinal cord transection in the lamprey is associated with early retrograde p-Erk signaling in injured reticulospinal (RS) axons. Here, we examined the subcellular distribution of p-Erk and its downstream effector p-Elk1 in identified RS neurons and assessed subsequent axon extension after pharmacological inhibition with the MEK inhibitor U0126. Immunofluorescence microscopy revealed increased p-Erk and p-Elk1 immunoreactivity and nuclear colocalization in identified I1 and M2/3 neurons at 1.5–3 h after transection, followed by a decline by 6 h. Oligo(dT) in situ hybridization revealed concomitant changes in RNA-associated staining patterns after injury. Acute local U0126 treatment effectively reduced Erk phosphorylation in spinal cord homogenates. In regeneration experiments, pooled axon extension distances were significantly greater in animals receiving continued bath treatment with U0126 at 2 and 3 weeks post-injury than in vehicle controls, and were qualitatively greater than in animals treated only acutely. These observations link early retrograde Erk pathway signaling with the somatic neuronal response to axotomy and identify sustained U0126 treatment as a promising candidate for further investigation in promoting functional axonal regeneration. However, the small number of animals and clustering of measurements within individual specimens limit within individual specimens inference regarding the specific treatment effects of U0126. Furthermore, long-term Erk activation and sustained target-tissue inhibition during chronic bath treatment were not empirically measured.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: